New flu prevention drug faces off against tamiflu in hospital trial
NCT ID NCT07236814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether two antiviral drugs—suraxavir marboxil and oseltamivir (Tamiflu)—can prevent flu from spreading to uninfected roommates of flu patients in hospitals. About 384 people will take one of the drugs or a placebo for 5 days. Researchers will track how many get the flu to see which approach works best.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Suraxavir marboxil and oseltamivir
What this could lead to
If successful, this could provide a new option to prevent flu transmission in hospitals, reducing outbreaks among patients and staff.
What could go wrong
This is a single trial with 384 participants, so results may not apply broadly. The drugs may cause side effects or prove no better than placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, China
Contact Email: •••••@•••••
-
China-Japan Friendship hospital, Beijing, Beijing
NOT_YET_RECRUITINGBeijing, Beijing Municipality, 100029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••